Header Logo

Mustafa Barbhuiya MSc, PhD

TitleAssistant Professor
InstitutionUMass Chan – Baystate Regional Campus
DepartmentPathology at UMass Chan - Baystate
AddressBaystate Health Regional Campus
759 Chestnut Street
Springfield MA 01199
Phone413-794-4512
vCardDownload vCard
    Other Positions
    InstitutionUMass Chan – Baystate Regional Campus
    DepartmentHealthcare Delivery and Population Sciences at UMass Chan - Baystate


    Collapse Biography 
    Collapse education and training
    Assam University, Silchar, AS, IndiaBSZoology
    Jiwaji University, Gwalior, MP, IndiaMSBiochemistry
    Jiwaji University, Gwalior, MP, IndiaPHDBiochemistry
    Collapse awards and honors
    2010State level Young Scientist Award in Medical Sciences and Physiology , Council of Science and Technology, Government of Madhya Pradesh, Bhopal, India
    2011National Young Scientist Award in Medical Sciences and Physiology, Indian Science Congress Association, Bhubaneswar, India
    2012Best Researcher Award , Council of Science and Technology, Government of Madhya Pradesh, Bhopal, India
    2015Travel Award from US-Human Proteome Organization , US HUPO 11th Annual Conference Next Generation Proteomics March 15 - 18, 2015 Tempe, Arizona, USA
    2015Poster of Distinction Award , Annual Meeting of American Association of Gastroenterology’ Washington, DC. May 16 – May 19, 2015
    2019Travel Award from the Office of Faculty and Professional Development , Penn State College of Medicine, Hershey, PA
    2019ASCP 40 Under Forty Honoree 2019, American Society of Clinical Pathology, USA
    2019Travel Award to attend Medical and Scientific Learning Exchange Program, Siemens Healthineers, Walpole, MA
    2019Best Abstract Award: Annual Research Retreat, Department of Pathology, Penn State University College of Medicine, Hershey, PA
    2019 - 2021Associate Fellow, Association of Clinical Scientists, USA
    2020Personalized Medicine Division (PMD) Outstanding Postdoc Abstract Award, American Association of Clinical Chemistry (AACC)
    2021Fellow of Association of Clinical Scientists, Association of Clinical Scientists, USA
    2021SYCL Travel Award, Society of Young Clinical Laboratorian, American Association of Clinical Chemistry (AACC)
    2022Associate Fellow, AACC Academy, American Association of Clinical Chemistry (AACC)

    Collapse Overview 
    Collapse Summary
    Dr. Mustafa Barbhuiya is currently the Medical Director of Clinical Chemistry and Point of Care Testing at the Department of Pathology, Baystate Medical Center, Springfield, MA. His basic and translational research interests include liver and biliary tract cancer biomarkers. He also conducts research on the role of essential diagnostics list in health care delivery and population health.
    Collapse overview

    Dr. Mustafa Barbhuiya completed the Clinical Chemistry Fellowship (2018-2020) at the Department of Pathology and Laboratory Medicine, Penn State University College of Medicine, Hershey. He earned a Doctorate in Biochemistry (2013) from Jiwaji University, Gwalior, India and subsequently completed postdoctoral studies (2013-2018) from Johns Hopkins University School of Medicine, Baltimore, USA. He is broadly trained in clinical biochemistry, clinical laboratory management, medical laboratory sciences, cancer epidemiology, cancer biomarkers, next generation sequencing and mass spectrometry. He is board certified as a clinical chemist and CMS approved high complexity clinical laboratory director. He is also American Society of Clinical Pathology board certified in Molecular Biology and Medical Laboratory Sciences.

    He was selected as one of the American Society for Clinical Pathologists’ (ASCP’s) 40 Under Forty 2019. The ‘ASCP 40 under forty’ program recognizes members under the age of 40 for their achievements and leadership qualities that are making an impact on pathology and laboratory medicine. He won several other national awards, serves in the committees of professional bodies like Association of Clinical Scientists, American Association of Clinical Chemistry (AACC) and Clinical Laboratory Standard Institute. He was elected Fellow of Association of Clinical Scientists and Associate Fellow of AACC Academy (formerly National Academy of Clinical Biochemistry).

    Dr. Barbhuiya set up a global non-profit organization called the Foundation for Advancement of Essential Diagnostics (FAED) in India (2018) and subsequently in USA (2020). The overall goal of this foundation is to promote and further augment the ‘essential diagnostics list’ published by World Health Organization in context to global public health. FAED aims to provide framework for a strong and functional evidence-based laboratory medicine regulatory system in to maintain and sustain the quality assurance and continuous improvement in the practice of laboratory medicine in low-resource settings in Asia, Latin America and Africa.


    Collapse webpage

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chakraborty B, Laskar AA, Baruah A, Kumar R, Barbhuiya MA. Critical Perspectives on Global Health Policy, Diagnostic Access and Practice Gaps towards a Tuberculosis Free India. Ann Clin Lab Sci. 2024 Nov; 54(6):721-738. PMID: 39855743.
      Citations:    
    2. Yang J, Barbhuiya MA, Hamilton C, Robyak K, Zhu Y. Analytical and Clinical Validation of an Automated Microfluidic Interleukin-6 Immunoassay. Ann Clin Lab Sci. 2024 May; 54(3):388-393. PMID: 39048159.
      Citations:    
    3. Barbhuiya MA, Livingston R, Baranoski S, Creer MH, Oladipo O. Comparative analysis of platelet depleted plasma prepared on the Roche 8100 automation line and manually centrifuged platelet poor plasma for routine coagulation assays. Pract Lab Med. 2023 Aug; 36:e00324. PMID: 37649543.
      Citations:    
    4. Chakraborty B, Nath S, Deb S, Baruah A, Paul M, Dutta SS, Barbhuiya MA. Analytical and Clinical Performance of Two Point of Care Rapid Antibody Assays for SARS-CoV-2. Ann Clin Lab Sci. 2023 May; 53(3):353-359. PMID: 37437941.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    5. Barbhuiya MA, Neibauer T, Saylor E, Zhu Y. Comparison of Performance between the Elecsys 4th and 5th Generation STAT Cardiac Troponin T Immunoassays. Ann Clin Lab Sci. 2022 Jul; 52(4):628-633. PMID: 36197775.
      Citations:    Fields:    Translation:Humans
    6. Barbhuiya MA, Reinhard H, Helm KF, Creer MH, Zhu Y. A Thirteen-Year-Old Boy with Rashes and Bumps on Arms and Legs. J Appl Lab Med. 2020 09 01; 5(5):1117-1121. PMID: 32674124.
      Citations:    Fields:    Translation:Humans
    7. Pandey A, Stawiski EW, Durinck S, Gowda H, Goldstein LD, Barbhuiya MA, Schr?der MS, Sreenivasamurthy SK, Kim SW, Phalke S, Suryamohan K, Lee K, Chakraborty P, Kode V, Shi X, Chatterjee A, Datta K, Khan AA, Subbannayya T, Wang J, Chaudhuri S, Gupta S, Shrivastav BR, Jaiswal BS, Poojary SS, Bhunia S, Garcia P, Bizama C, Rosa L, Kwon W, Kim H, Han Y, Yadav TD, Ramprasad VL, Chaudhuri A, Modrusan Z, Roa JC, Tiwari PK, Jang JY, Seshagiri S. Integrated genomic analysis reveals mutated ELF3 as a potential gallbladder cancer vaccine candidate. Nat Commun. 2020 08 24; 11(1):4225. PMID: 32839463.
      Citations: 22     Fields:    Translation:HumansCells
    8. Bhunia S, Barbhuiya MA, Gupta S, Shrivastava BR, Tiwari PK. Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression. Indian J Med Res. 2020 04; 151(4):311-318. PMID: 32461394.
      Citations: 2     Fields:    Translation:HumansCells
    9. Barbhuiya MA, Pederson EC, Straub ML, Neibauer TL, Salter WF, Saylor EL, Scott SC, Zhu Y. Automated Measurement of Plasma Cell-Free Hemoglobin Using the Hemolysis Index Check Function. J Appl Lab Med. 2020 03 01; 5(2):281-289. PMID: 32445381.
      Citations: 1     Fields:    Translation:Humans
    10. Dhanasekaran R, Baylot V, Kim M, Kuruvilla S, Bellovin DI, Adeniji N, Rajan Kd A, Lai I, Gabay M, Tong L, Krishnan M, Park J, Hu T, Barbhuiya MA, Gentles AJ, Kannan K, Tran PT, Felsher DW. MYC and Twist1 cooperate to drive metastasis by eliciting crosstalk between cancer and innate immunity. Elife. 2020 01 14; 9. PMID: 31933479.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    11. Donaldson K, Buchanich JM, Grigson PS, Deneke E, Donaldson K, Vrana KE, Sacks DB, Kuehn GJ, Cardamone D, Pesce A, Smiley S, Nickley J, Krock K, Thomas R, Wilkerson ML, Farag HA, Challa SR, Tice AM, Wolk DM, Prichard J, Grant ML, Regmi S, Kerbacher B, Quinton LE, Farag HA, Tice AM, Wolk DM, Olson J, Haynes A, Yu E, McCully KS, Assi J, Wong M, Zarrin-Khameh N, Nifong TP, Hawker CD, Carlton GT, Rivera JM, Foulis PR, Zuraw A, Morlote D, Peker D, Reddy V, Harada S, Crutchfield C, Zander D, Barbhuiya MA, Pederson EC, Straub ML, Scott SC, Neibauer TL, Salter WF, Creer MH, Zhu Y, Bornhorst JA, Theobald JP, Algeciras-Schimnich A, Cao L, Knox J, Hardy R, Texas HJ, McGuire MF, Hunter RL, Brown RE, Hicks J, Hicks J, Cai Z, Brown RE, Ali Y, Cheng KC, Katz SR, Ding Y, Vanselow DJ, Yakovlev MA, Lin AY, Clark DP, Vargas P, Xin X, Copper JE, Canfield VA, Ang KC, Wang Y, Xiao X, De Carlo F, van Rossum DB, La Rivi?re PJ, Newell J, Hossler C, Roche M, Warrick J, Phaeton R, Kesterson J, Donaldson K, Myers C, Barrios R, Mintz P, Robyak K, Hamilton C, McGhee P, Pederson C, Straub M, Scott S, Neibauer T, Salter W, Creer M, Zhu Y, Hamilton C, Robyak K, McGhee P, Pederson C, Straub M, Scott S, Neibauer T, Salter W, Creer M, Zhu Y, Singh N, Morlote D, Vnencak-Jones C, Yemelyanova A, Harada S, Shah M, Moghadamtousi SZ, Lan C, Duose D, Hu P, Esquenazi Y, Luthra R, Ballester LY, Koenig AN, Liu CG, Zhang J, Kalia A, Al-Habib A, Van Arsdall M, Dhingra S, Patel K, Tatevian N. Abstracts of Presentations at the Association of Clinical Scientists 139th Meeting Hershey, PA, May 15-18, 2019. Ann Clin Lab Sci. 2019 05; 49(3):403-416. PMID: 31308044.
      Citations:    Fields:    
    12. Subbannayya T, Leal-Rojas P, Zhavoronkov A, Ozerov IV, Korzinkin M, Babu N, Radhakrishnan A, Chavan S, Raja R, Pinto SM, Patil AH, Barbhuiya MA, Kumar P, Guerrero-Preston R, Navani S, Tiwari PK, Kumar RV, Prasad TSK, Roa JC, Pandey A, Sidransky D, Gowda H, Izumchenko E, Chatterjee A. PIM1 kinase promotes gallbladder cancer cell proliferation via inhibition of proline-rich Akt substrate of 40?kDa (PRAS40). J Cell Commun Signal. 2019 Jun; 13(2):163-177. PMID: 30666556.
      Citations:    
    13. Taparra K, Wang H, Malek R, Lafargue A, Barbhuiya MA, Wang X, Simons BW, Ballew M, Nugent K, Groves J, Williams RD, Shiraishi T, Verdone J, Yildirir G, Henry R, Zhang B, Wong J, Wang KK, Nelkin BD, Pienta KJ, Felsher D, Zachara NE, Tran PT. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis. J Clin Invest. 2018 11 01; 128(11):4924-4937. PMID: 30130254.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    14. Barbhuiya MA, Kashyap MK, Puttamallesh VN, Kumar RV, Wu X, Pandey A, Gowda H. Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays. Oncotarget. 2018 Apr 06; 9(26):18422-18434. PMID: 29719615.
      Citations: 2     Fields:    
    15. Na CH, Barbhuiya MA, Kim MS, Verbruggen S, Eacker SM, Pletnikova O, Troncoso JC, Halushka MK, Menschaert G, Overall CM, Pandey A. Discovery of noncanonical translation initiation sites through mass spectrometric analysis of protein N termini. Genome Res. 2018 01; 28(1):25-36. PMID: 29162641.
      Citations: 38     Fields:    Translation:HumansCells
    16. Barbhuiya MA, Mirando AC, Simons BW, Lemtiri-Chlieh G, Green JJ, Popel AS, Pandey NB, Tran PT. Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma. Oncotarget. 2017 Nov 24; 8(60):101520-101534. PMID: 29254183.
      Citations: 7     Fields:    
    17. Weber H, Valbuena JR, Barbhuiya MA, Stein S, Kunkel H, Garc?a P, Bizama C, Riquelme I, Espinoza JA, Kurtz SE, Tyner JW, Calderon JF, Corval?n AH, Grez M, Pandey A, Leal-Rojas P, Roa JC. Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer. Oncotarget. 2017 Apr 18; 8(16):26169-26184. PMID: 28412732.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    18. Wu X, Zahari MS, Renuse S, Kelkar DS, Barbhuiya MA, Rojas PL, Stearns V, Gabrielson E, Malla P, Sukumar S, Mahajan NP, Pandey A. The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer. Oncotarget. 2017 01 10; 8(2):2971-2983. PMID: 27902967.
      Citations: 20     Fields:    Translation:HumansAnimalsCells
    19. Sharma P, Bhunia S, Poojary SS, Tekcham DS, Barbhuiya MA, Gupta S, Shrivastav BR, Tiwari PK. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease. Tumour Biol. 2016 Nov; 37(11):14687-14699. PMID: 27623942.
      Citations: 10     Fields:    Translation:HumansCells
    20. Tekcham DS, Poojary SS, Bhunia S, Barbhuiya MA, Gupta S, Shrivastav BR, Tiwari PK. Epigenetic regulation of APC in the molecular pathogenesis of gallbladder cancer. Indian J Med Res. 2016 May; 143(Supplement):S82-S90. PMID: 27748282.
      Citations: 2     Fields:    Translation:HumansCells
    21. Subbannayya T, Leal-Rojas P, Barbhuiya MA, Raja R, Renuse S, Sathe G, Pinto SM, Syed N, Nanjappa V, Patil AH, Garcia P, Sahasrabuddhe NA, Nair B, Guerrero-Preston R, Navani S, Tiwari PK, Santosh V, Sidransky D, Prasad TS, Gowda H, Roa JC, Pandey A, Chatterjee A. Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer. BMC Cancer. 2015 Nov 04; 15:843. PMID: 26530123.
      Citations: 17     Fields:    Translation:HumansCells
    22. Wu X, Zahari MS, Ma B, Liu R, Renuse S, Sahasrabuddhe NA, Chen L, Chaerkady R, Kim MS, Zhong J, Jelinek C, Barbhuiya MA, Leal-Rojas P, Yang Y, Kashyap MK, Marimuthu A, Ling M, Fackler MJ, Merino V, Zhang Z, Zahnow CA, Gabrielson E, Stearns V, Roa JC, Sukumar S, Gill PS, Pandey A. Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Oct 06; 6(30):29143-60. PMID: 26356563.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    23. Syed N, Barbhuiya MA, Pinto SM, Nirujogi RS, Renuse S, Datta KK, Khan AA, Srikumar K, Prasad TS, Kumar MV, Kumar RV, Chatterjee A, Pandey A, Gowda H. Phosphotyrosine profiling identifies ephrin receptor A2 as a potential therapeutic target in esophageal squamous-cell carcinoma. Proteomics. 2015 Jan; 15(2-3):374-82. PMID: 25366905.
      Citations: 12     Fields:    Translation:HumansCells
    24. Subbannayya Y, Syed N, Barbhuiya MA, Raja R, Marimuthu A, Sahasrabuddhe N, Pinto SM, Manda SS, Renuse S, Manju HC, Zameer MA, Sharma J, Brait M, Srikumar K, Roa JC, Vijaya Kumar M, Kumar KV, Prasad TS, Ramaswamy G, Kumar RV, Pandey A, Gowda H, Chatterjee A. Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma. Cancer Biol Ther. 2015; 16(2):336-45. PMID: 25756516.
      Citations: 37     Fields:    Translation:HumansCells
    25. Sahasrabuddhe NA, Barbhuiya MA, Bhunia S, Subbannayya T, Gowda H, Advani J, Shrivastav BR, Navani S, Leal P, Roa JC, Chaerkady R, Gupta S, Chatterjee A, Pandey A, Tiwari PK. Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics. Biochem Biophys Res Commun. 2014 Apr 18; 446(4):863-9. PMID: 24657443.
      Citations: 18     Fields:    Translation:Humans
    26. Barbhuiya M, Bhunia S, Kakkar M, Shrivastava B, Tiwari PK, Gupta S. Fine needle aspiration cytology of lesions of liver and gallbladder: An analysis of 400 consecutive aspirations. J Cytol. 2014 Jan; 31(1):20-4. PMID: 25190979.
      Citations:    
    27. Marimuthu A, Chavan S, Sathe G, Sahasrabuddhe NA, Srikanth SM, Renuse S, Ahmad S, Radhakrishnan A, Barbhuiya MA, Kumar RV, Harsha HC, Sidransky D, Califano J, Pandey A, Chatterjee A. Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome. Biochim Biophys Acta. 2013 Nov; 1834(11):2308-16. PMID: 23665456.
      Citations: 29     Fields:    Translation:HumansCells
    28. Barbhuiya MA, Sahasrabuddhe NA, Pinto SM, Muthusamy B, Singh TD, Nanjappa V, Keerthikumar S, Delanghe B, Harsha HC, Chaerkady R, Jalaj V, Gupta S, Shrivastav BR, Tiwari PK, Pandey A. Comprehensive proteomic analysis of human bile. Proteomics. 2011 Dec; 11(23):4443-53. PMID: 22114102.
      Citations: 18     Fields:    Translation:Humans
    29. Singh TD, Barbhuiya MA, Gupta S, Shrivastav BR, Jalaj V, Agarwal N, Tiwari PK. Quantitative Assessment of Expression of Lactate Dehydrogenase and its Isoforms 3 and 4 may Serve as Useful Indicators of Progression of Gallbladder Cancer: A Pilot Study. Indian J Clin Biochem. 2011 Apr; 26(2):146-53. PMID: 22468041.
      Citations:    
    Barbhuiya's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (176)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _